Detection of Proteus mirabilis in Healthy, sick and Diarrheal Dogs, Cats and Humans
DOI:
https://doi.org/10.37506/ijfmt.v15i2.14621Keywords:
Proteus mirabilis, dogs and cats, VITEK®, Api20, AntibioticsAbstract
The current work was conducted for isolation, identification and epidemiological frequency and distribution
of Proteus mirabilis from humans and Dogs, cats, scanning Vitek in addition (PCR) assay was confirm
detect isolates and Api 20E technique is also used in order diagnosis of P. mirabilis then determination
of antibiotics susceptibility pattern of recovered isolates. The human isolates showed that (89.47%) were
resistant Ampicillin, (42.10%) Ofloxacin, (57.14%) Cefoxitin, (57.14%) Gentamycin, (100%) Vancomycin,
(57.14%) Chloramphenicol, (89.47%) Trimethoprim, (100%) Amoxiclav, (57.89%) Streptomycin, (100%)
Tetracycline, (89.47%) Penicillin, (100%) Erythromycin. The dogs isolates showed resistance (64.28%) was
resistant Ampicillin, (35.71%) Ofloxacin, (46.1%) Cefoxitin, (53.8%) Gentamycin, (64.28%) Vancomycin,
(47.3%) Chloramphenicol, (64.28%) Trimethoprim, (64.28%) Amoxiclav, (42.85%) Streptomycin, (64.28%)
Tetracycline, (64.28%) Penicillin, (64.28%) Erythromycin, otherwise the cat’s isolates showed resistance
(35.71%) were Ampicillin -resistant, for Ofloxacin (35.71%), for Cefoxitin (35.71%), for Gentamycin
(35.71%), for Vancomycin (35.71%), for Chloramphenicol (35.71%), for Trimethoprim (35.71%), for
Amoxiclav (35.71%), for Streptomycin (35.71%), for Tetracycline (35.71%), for Penicillin (35.71%), for
Erythromycin (35.71%). The Proteus mirabilis was isolated from 33 out of 195 sample (16.92%) distributed
as 19 isolated from human and 14 from Dogs and Cats. The human isolates showed that (89.47%) were
resistant Ampicillin, (42.10%) Ofloxacin, (57.14%) Cefoxitin, (57.14%) Gentamycin, (100%) Vancomycin,
(57.14%) Chloramphenicol, (89.47%) Trimethoprim, (100%) Amoxiclav, (57.89%) Streptomycin, (100%)
Tetracycline, (89.47%) Penicillin, (100%) Erythromycin.
Downloads
Published
Issue
Section
License
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions